Antiangiogenic Agents in Combination with Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer

Author： Ulahannan Susanna V. Brahmer Julie R.

ISSN： 0735-7907

Source： Cancer Investigation, Vol.29, Iss.4, 2011-04, pp. : 325-337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A phase II study of docetaxel and vinorelbine combination chemotherapy in patients with advanced non-small cell lung cancer

By Bennouna J. Monnier A. Riviere A. Milleron B. Lemarie E. Trillet-Lenoir V. Soussan-Lazard K. Berille J. Douillard J.Y.

European Journal of Cancer, Vol. 36, Iss. 9, 2000-06 ,pp. : 1107-1112

Elsevier

Access to resources Recommend Favorite

Comparative analysis of carboplatin and paclitaxel combination chemotherapy schedules in previously untreated patients with advanced non-small cell lung cancer

Oncology Letters, Vol. 5, Iss. 3, 2013-01 ,pp. : 761-767

Spandidos Publications

Access to resources Recommend Favorite

Triplet chemotherapy combination with cisplatin, gemcitabine and docetaxel in patients with chemotherapynaive advanced non-small cell lung cancer

Oncology Letters, Vol. 5, Iss. 5, 2013-01 ,pp. : 1699-1703

Spandidos Publications

Access to resources Recommend Favorite

A multi-institutional phase II study of combination chemotherapy with S-1 plus cisplatin in patients with advanced non-small cell lung cancer

Oncology Letters, Vol. 2, Iss. 3, 2011-01 ,pp. : 465-470

Spandidos Publications

Access to resources Recommend Favorite

A prospective study of the efficacy of a combination of autologous dendritic cells, cytokine-induced killer cells, and chemotherapy in advanced non-small cell lung cancer patients

By Zhong Runbo Han Baohui Zhong Hua

Tumor Biology, Vol. 35, Iss. 2, 2014-02 ,pp. : 987-994

Springer Publishing Company

Access to resources Recommend Favorite